Cargando…

Development of Heart Failure in Medicaid Patients with Type 2 Diabetes Treated with Pioglitazone, Rosiglitazone, or Metformin

BACKGROUND: Medicaid covers a high-risk population typically underrepresented in clinical trial data and largely absent in observational studies of real-world cardiovascular risks associated with thiazolidinediones (TZDs), such as pioglitazone and rosiglitazone, which are used to manage type 2 diabe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Breunig, Ian M., Shaya, Fadia T., McPherson, Mary Lynn, Snitker, Soren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438200/ https://www.ncbi.nlm.nih.gov/pubmed/25166288 http://dx.doi.org/10.18553/jmcp.2014.20.9.895

Ejemplares similares

Utilization and Costs for Compliant Patients Initiating Therapy With Pioglitazone or Rosiglitazone Versus Insulin in a Medicaid Fee-for-Service Population
por: Kalsekar, Iftekhar, et al.
Publicado: (2006)

Rosiglitazone and Pioglitazone Alter Aromatase Kinetic Properties in Human Granulosa Cells
por: Araki, Takako, et al.
Publicado: (2011)

Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings
por: Niyomnaitham, Suvimol, et al.
Publicado: (2014)

Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats
por: Rao, Ravi Prakash, et al.
Publicado: (2011)

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study
por: Juurlink, David N, et al.
Publicado: (2009)

Evaluation of Osteopontin Gene Expression in Endometrium of Diabetic Rat Models Treated with Metformin and Pioglitazone
por: Hosseiny, Zeinab Sadat, et al.
Publicado: (2019)

Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
por: Deeg, Mark A., et al.
Publicado: (2008)

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
por: Berthet, Stephanie, et al.
Publicado: (2011)

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
por: Colhoun, H. M., et al.
Publicado: (2012)

Influence of health warnings on the use of rosiglitazone and pioglitazone in an area of Spain: A time-series study
por: Carracedo-Martínez, Eduardo, et al.
Publicado: (2016)

Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2009)

Simultaneous Estimation of Metformin and Pioglitazone by Ultraviolet Spectrophotometry
por: Goswami, Laxmi, et al.
Publicado: (2010)

Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2010)

Influence of pioglitazone on experimental heart failure and hyperlipidemia in rats
por: Biswas, Arghya, et al.
Publicado: (2012)

Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY
Publicado: (2013)

Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis
por: Xu, Yifeng, et al.
Publicado: (2017)

Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin
por: Ohira, Masahiro, et al.
Publicado: (2014)

The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety
por: Leonard, Charles E., et al.
Publicado: (2020)

Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated With Five Risk-Warning Events
por: Starner, Catherine I., et al.
Publicado: (2008)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holland, Daniel Q, et al.
Publicado: (2014)

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial
por: Komajda, Michel, et al.
Publicado: (2010)

Formulation and Evaluation of Multilayered Tablets of Pioglitazone Hydrochloride and Metformin Hydrochloride
por: Chowdary, Y. Ankamma, et al.
Publicado: (2014)

Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes
por: Esteghamati, Alireza, et al.
Publicado: (2013)

Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT
por: Kahn, Steven E., et al.
Publicado: (2011)

Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular Mortality
por: Wilson, Kitchener D., et al.
Publicado: (2008)

Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
por: Kim, Jong Ho, et al.
Publicado: (2016)

Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin
por: Jonker, Jacqueline T, et al.
Publicado: (2009)

Metformin in combination with rosiglitazone contribute to the increased serum adiponectin levels in people with type 2 diabetes mellitus
por: Nie, Jie-Ming, et al.
Publicado: (2017)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
por: Shahebrahimi, Karoon, et al.
Publicado: (2016)

Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
por: Liu, Jieying, et al.
Publicado: (2023)

Unmasking Differential Effects of Rosiglitazone and Pioglitazone in the Combination Treatment with n-3 Fatty Acids in Mice Fed a High-Fat Diet
por: Kus, Vladimir, et al.
Publicado: (2011)

Combined intervention with pioglitazone and n-3 fatty acids in metformin-treated type 2 diabetic patients: improvement of lipid metabolism
por: Veleba, Jiri, et al.
Publicado: (2015)

Metformin in heart failure patients
por: Kinsara, Abdulhalim Jamal, et al.
Publicado: (2018)

Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure
por: Goltsman, Ilia, et al.
Publicado: (2019)

Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin
por: DeFronzo, Ralph A., et al.
Publicado: (2010)

Diabetic retinopathy
por: Shaya, Fadia T, et al.
Publicado: (2007)

Pioglitazone and sulfonylureas: effectively treating type 2 diabetes
por: Hanefeld, M
Publicado: (2007)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone
por: Forst, T, et al.
Publicado: (2014)

Comparative Study on Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin
por: Jameshorani, Maryam, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sv6qc5qb7ti2lf1au8s9kudain